No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis
2013
Objective
The use of anti-tumor necrosis factor (TNF) agents to treat joint manifestations of sarcoidosis has not been described. We evaluated the efficacy and safety of three such biologics in patients with these symptoms refractory to conventional therapy (nonsteroidal anti-inflammatory drugs, corticosteroids, and/or disease-modifying antirheumatic drugs).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
27
References
8
Citations
NaN
KQI